Immunotherapy with mosquito (Culex quinquefasciatus) extract: A double-blind, placebo-controlled study

Annals of Allergy, Asthma and Immunology

Volumn 99, Issue 3, 2007, Pages 273-280

  Srivastava, Deepsikha ^a,b   Singh, Bhanu P ^a   Sudha, V Thangam ^a,b   Arora, Naveen ^a   Gaur, Shailendra N ^c  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b UNIVERSITY OF PUNE   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; MOSQUITO ALLERGEN; PLACEBO; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULEX QUINQUEFASCIATUS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; IMMUNOTHERAPY; INSECT ALLERGY; INSECT BITE; INTRACUTANEOUS TEST; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SENSITIZATION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT;

EID: 34548666613     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60664-3     Document Type: Article

References (40)

1. Golden DBK. Epidemiology of allergy to insect venoms and stings. Allergy Proc. 1989;16:103-107.
2. Fan P-C, Chang H-N. Hypersensitivity to mosquito bites: a case report. Gaoxiong Yi Xue Ke Xue Za Zhi 1995;11:420-424.
3. Gupta S, Jain S, Chaudhry S, Agarwal MK. Role of insects as inhalant allergens in bronchial asthma with special reference to the clinical characteristics of patients. Clin Exp Allergy. 1990;20:519-524.
4. Agarwal MK, Chaudhry S, Jhamb S, Gaur SN, Chauhan UP, Agarwal HC. Etiologic significance of mosquito (Anopheles stephensi) in respiratory allergy in India. Ann Allergy. 1991;67:598-602.
5. Christophers SR. Aedes aegypti (L.) the Yellow Fever Mosquito: Its Life History, Bionomics and Structure. London, England: Cambridge University Press; 1960:739.
6. Pawankar R, Yamagishi S, Takizawa R, Yagi T. Mast cell-IgE-and mast cell-structural cell interactions in allergic airway disease. Curr Drug Targets Inflamm Allergy. 2003;2:303-312.
7. Ariano R, Berto P, Tracci D, Incorvaia C, Frati F. Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma. Allergy Asthma Proc. 2006;27:159-163.
8. Abramson M, Puy R, Weiner J, Mailing HJ. Immunotherapy as an effective tool in allergy treatment. Allergy. 1998;53:461-472.
9. Crimi N, Li Gotti F, Mangano G, et al. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms. Ann Ital Med Int. 2004;19:98-108.
10. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy: a six-year follow-up study. Clin Exp Allergy. 2001;31:1392-1397.
11. Wachholz PA, Soni NK, Till SJ, Durham SR. Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol. 2003;112:915-922.
12. Abramson M, Puy R, Weiner J. Immunotherapy in asthma: an updated systematic review. Allergy. 1999;54:1022-1041.
13. Karmakar PR, Das A, Chatterjee BP. Placebo-controlled immunotherapy with Cocos nucifera pollen extract. Int Arch Allergy Immunol. 1994;103:194-201.
14. Chowdhury I, Chatterjee B. The immunological and clinical effects of immunotherapy in patients suffering from house dust allergy. Ann Agric Environ Med. 1999;6:91-97.
15. Gaur SN, Gupta S. Clinical response of immunotherapy in case of nasobronchial allergy. Indian J Allergy Appl Immunol. 1996;10:65-68.
16. Peng Z, Yang M, Simons FE. Measurement of mosquito Aedes vexans salivary gland-specific IgE and IgG antibodies and the distribution of the antibodies in human sera. Ann Allergy Asthma Immunol. 1995;74:259-264.
17. Peng Z, Yang M, Simons FER. Immunological mechanisms in mosquito allergy: correlations of skin reactions with specific IgE and IgG antibodies and lymphocyte proliferation response to mosquito antigens. Ann Allergy Asthma Immunol. 1996;77:238-244.
18. McCormack DR, Salata KF, Hershey JN, Carpenter GB, Engler RJ. Mosquito bite anaphylaxis: immunotherapy with whole body extracts. Ann Allergy Asthma Immunol. 1995;74:39-44.
19. Ariano R, Panzani RC. Efficacy and safety of specific immunotherapy to mosquito bites. Allerg Immunol (Paris). 2004;36:131-138.
20. Benaim-Pinto C, Fassrainer A. Intradermal immunotherapy in children with severe skin inflammatory reactions to Aedes aegypti and Culex quinquefasciatus mosquito bites. Int J Dermatol. 1990;29:600-601.
21. Kausar MA, Vijayan VK, Bansal SK, Gupta M, Menon BK, Agarwal MK. Mosquito (Culex quinquefasciatus) induced IgE response is type I allergic respiratory disorders: a clinico immunologic studies. Indian J Allergy Asthma Immunol. 2005;19:102-103.
22. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144:1202-1218.
23. Adamopoulos G, Manolopoulos L, Giotakis I. A comparison of the efficacy and the patient acceptability of budesonide and beclomethasone diproprionate aqueous nasal sprays in patients with perennial rhinitis. Clin Otolaryngol. 1995;20:340-344.
24. Thangam Sudha V, Arora N, Sridhara S, Gaur SN, Singh BP. Biopotency and identification of allergenic proteins in Periplaneta americana extract for clinical applications. Biologicals. 2007;35:131-137.
25. Shankar J, Singh BP, Gaur SN, Arora N. Recombinant glutathione-S- transferase a major allergen from Alternaria alternata for clinical use in allergy patients. Mol Immunol. 2006;43:1927-1932.
26. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing - 1999. Am J Respir Crit Care Med. 2000;161:309-329.
27. Singh AK, Mehta AK, Sridhara S, et al. Allergenicity assessment of transgenic mustard (Brassica juncea) expressing bacterial codA gene. Allergy. 2006;61:491-497.
28. Soderlund A, Gabrielsson S, Paulie S, Hammarstrom ML, Rak S, Troye-Blomberg M. Allergen induced cytokine profiles in type I allergic individuals before and after immunotherapy. Immunol Lett. 1997;57:177-181.
29. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2003;(4):CD001186.
30. Maestrelli P, Zanolla L, Pozzan M, Fabbri LM. Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite. J Allergy Clin Immunol. 2004;113:643-649.
31. Iliopoulos O, Proud D, Adkinson NF, et al. Effects of immunotherapy on the early, late and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol. 1991;87:855-866.
32. Lipworth BJ, Jackson CM. Second-line controller therapy for persistent asthma uncontrolled on inhaled corticosteroids: the step 3 dilemma. Drugs. 2002;62:2315-2332.
33. Walker SM, Pajno GB, Lima MT, Wilson DR, Durham SR. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol. 2001;107:87-93.
34. Garcia-Robaina JC, Sanchez I, de la Torre F, Fernandez-Caldas E, Casanovas M. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study. J Allergy Clin Immunol. 2006;118:1026-1032.
35. Sheikh WA, Immunotherapy vs. inhaled budesonide in bronchial asthma: an open, parallel, comparative trial. Clin Exp Allergy. 1997;27:1279-1284.
36. Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol. 1998;102:157-164.
37. Nagakawa T, Kozeki H, Katagiri J, et al. Changes of house dust mite-specific IgE, IgG and IgG subclass antibodies during immunotherapy in patients with perennial rhinitis. Int Arch Allergy Appl Immunol. 1987;82:95-99.
38. Gehlhar K, Schlaak M, Becker W, Bufe A. Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome. Clin Exp Allergy. 1999;29:497-506.
39. Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Sackesen C, Kalayci O. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Pediatr Allergy Immunol. 2006;17:396-407.
40. Garcia BE, Sanz ML, Gato JJ, Fernandez J, Oehling A. IgG4 blocking effect on the release of antigen-specific histamine. J Investig Allergol Clin Immunol. 1993;3:26-33.